JOEL S BENNETT
Medical Practice in Delaware
License number
Pennsylvania MD010626E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Delaware
Rosemont, PA 19010
Rosemont, PA 19010
Personal information
See more information about JOEL S BENNETT at radaris.comName
Address
Phone
4751 Hulmeville Rd, Bensalem, PA 19020
636 Clyde Rd, Bryn Mawr, PA 19010
1272 Myers Rd, Greensburg, PA 15601
Professional information
Inhibitors Of Integrin Alpha2Beta1 With Modified Urea Moiety
US Patent:
7910609, Mar 22, 2011
Filed:
Sep 24, 2008
Appl. No.:
12/237015
Inventors:
William F. DeGrado - Media PA, US
Seth E. Snyder - Hackensack NJ, US
Meredith W. Miller - Philadelphia PA, US
Sandeep Basra - Munich, DE
Joel S. Bennett - Bryn Mawr PA, US
Sungwook Choi - San Diego CA, US
Seth E. Snyder - Hackensack NJ, US
Meredith W. Miller - Philadelphia PA, US
Sandeep Basra - Munich, DE
Joel S. Bennett - Bryn Mawr PA, US
Sungwook Choi - San Diego CA, US
Assignee:
The Trustees Of The University Of Pennsylvania - Philadelphia PA
International Classification:
A01N 43/00, A61K 31/397, C07D 277/00, C07D 205/00
US Classification:
514327, 548200, 548953
Abstract:
Novel compounds inhibiting the integrin α2β1/GPIa-IIa receptor are disclosed. Also disclosed are pharmaceutical compositions containing the compounds, as well as methods of their therapeutic use. The compounds disclosed are useful, inter alia, as inhibitors of integrin α2β1/GPIa-IIa-mediated activity.
Inhibitors Of Integrin Alpha2Beta1 Based On Prolyl Diaminopropionic Acid Scaffold
US Patent:
2010017, Jul 15, 2010
Filed:
Sep 24, 2009
Appl. No.:
12/566162
Inventors:
William F. DeGrado - Media PA, US
Meredith W. Miller - Philadelphia PA, US
Sandeep Basra - Munchen, DE
Joel S. Bennett - Bryn Mawr PA, US
Sungwook Choi - San Diego CA, US
Meredith W. Miller - Philadelphia PA, US
Sandeep Basra - Munchen, DE
Joel S. Bennett - Bryn Mawr PA, US
Sungwook Choi - San Diego CA, US
International Classification:
A61K 31/40, C07D 207/16, C07D 211/60, C07D 217/26, C07D 215/48, C07D 277/06, C07D 263/06, A61K 31/397, A61K 31/445, A61K 31/472, A61K 31/47, A61K 31/426, A61K 31/421, A61P 9/00, A61P 9/10, A61P 3/10, A61P 35/00, A61P 31/12
US Classification:
51421017, 548537, 546225, 546143, 546159, 548200, 548215, 514423, 514329, 514309, 514312, 514365, 514374
Abstract:
Novel compounds inhibiting the integrin α2β1/GPIa-IIa receptor are disclosed. Also disclosed are pharmaceutical compositions containing the compounds, as well as methods of their therapeutic use. The compounds disclosed are useful, inter alia, as inhibitors of integrin α2β1/GPIa-IIa-mediated activity.
Inhibitors Of The Α2Β1/Gpia-Iia Integrin
US Patent:
8258159, Sep 4, 2012
Filed:
Jun 7, 2006
Appl. No.:
11/916746
Inventors:
William F. DeGrado - Media PA, US
Joel S. Bennett - Bryn Mawr PA, US
Seth Elliott Snyder - Bronx NY, US
Sungwook Choi - San Diego CA, US
Joel S. Bennett - Bryn Mawr PA, US
Seth Elliott Snyder - Bronx NY, US
Sungwook Choi - San Diego CA, US
Assignee:
The Trustees Of The University Of Pennsylvania - Philadelphia PA
International Classification:
A01N 43/40, A01N 43/36, A61K 31/445, A61K 31/40
US Classification:
514327, 514423
Abstract:
Novel compounds inhibiting the integrin α2β1/GPIa-IIa receptor are disclosed. Also disclosed are pharmaceutical compositions containing the compounds, as well as methods of their therapeutic use. The compounds disclosed are useful, inter alia, as inhibitors of integrin α2β1/GPIa-IIa-mediated activity.